Medicus Sciences Acquisition Overview
Medicus Sciences Acquisition (MSAC) has a P/E ratio of 56.5, above the sector sector average of 44.85.
Get informed when a big investor buys or sells
+ Follow56.50
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, MSAC shows a P/E ratio of 56.5. That is above the sector sector average of 44.85. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 44.85. Medicus Sciences Acquisition is at 56.5, which is higher that average. That is roughly 26.0% above the sector mean. Use the comparison chart on this page to see how MSAC stacks up against individual peers as well.
Investors watch MSAC's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Medicus Sciences Acquisition's latest reading is 56.5. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Medicus Sciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 56.5) with ownership activity and broader fundamentals.
